ClickCease

Uterine Fibroids

Uterine Fibroids Treatment

Uterine Fibroids: The African-American Disparity

It is estimated that around 25 million women between the ages of 15 to 50 have uterine fibroids. Of these women, at least 15 million will endure heavy symptoms and have health problems associated with fibroids. Almost a quarter of African-American women between the ages of 18 and 30 have fibroids. By the time they reach the age of 35, this number increases to 60% due to various reasons and potential risk factors that are both hereditary, environmental and sociological.

Uterine Fibroids: The African-American Disparity Read More »

Fibroids

Acessa™ Fibroid Treatment Versus Uterine Fibroid Embolization (UFE)

Uterine Fibroid Embolization (UFE) and the Acessa™ procedure are treatments for uterine fibroids that are an alternate to hysterectomy or myomectomy. Acessa™ however, can only be performed by OB/GYN physicians in an operating room setting with general anesthesia, whereas UFE is available nationally as an outpatient procedure performed under local anesthesia by experienced interventional radiologists.

Acessa™ Fibroid Treatment Versus Uterine Fibroid Embolization (UFE) Read More »

Anemia

Fibroids and Anemia

Fibroids and Anemia Are Connected:

Heavy or excessive bleeding means a woman suffering from fibroids will also lose large quantities of iron and hemoglobin, causing a depletion of oxygen in her body, which leads to iron-deficiency anemia. People who are anemic experience fatigue, dizziness, confusion, and an overall sense of weakness.

Fibroids and Anemia Read More »

Scroll to Top